Use of Bedrocan and Tilray (FOI)
Use of Bedrocan and Tilray (FOI)Produced by the Freedom of Information office
Authored by Government of Jersey and published on 13 August 2019.
Prepared internally, no external costs.
As we are a year and a half on from former Health Minister the then Senator Green's Bedrocan and Tilray amendment being passed to the law draftsman's office, would you be able to provide an update on this and where it stands in relation to Deputy Renouf's changes of this year regarding cannabis?
Could this amendment be used to put Bedrocan and Tilray products on the list of States approved / paid prescriptions? Allowing all access not just those who can afford it.
The changes in legislation put forward by Deputy Renouf, the Health and Social Services Minister, earlier this year removed the legal barrier to prescribing quality assured cannabis-based medicinal products, such as Bedrocan and Tilray. Such products can now be legally prescribed by any doctor or approved prescriber in Jersey. The decision to prescribe is a clinical one taken by the prescriber.
Information is available at the following link to the response to Written Question 82/2019 in the States Assembly on 12 February 2019:
Written Question 82/2019
23 Information accessible to applicant by other means
(1) Information is absolutely exempt information if it is reasonably available to the applicant, otherwise than under this Law, whether or not free of charge.
(2) A scheduled public authority that refuses an application for information on this ground must make reasonable efforts to inform the applicant where the applicant may obtain the information.